Endocrine cells develop within pancreatic bud-like structures derived from mouse ES cells differentiated in response to BMP4 and retinoic acid

Abstract

We have examined factors affecting the in vitro differentiation of Pdx1^GFP/w ESCs to pancreatic endocrine cells. Inclusion of Bone Morphogenetic Protein 4 (BMP4) during the first four days of differentiation followed by a 24-hour pulse of retinoic acid (RA) induced the formation of GFP⁺ embryoid bodies (EBs). GFP expression was restricted to E-cadherin⁺ tubes and GFP bright (GFP^br) buds, reminiscent of GFP⁺ early foregut endoderm and GFP^br pancreatic buds observed in Pdx1^GFP/w embryos. These organoid structures developed without further addition of exogenous factors between days 5 and 12, suggesting that day 5 EBs contained a template for the subsequent phase of development. EBs treated with nicotinamide after day 12 of differentiation expressed markers of endocrine and exocrine differentiation, but only in cells within the GFP^br buds. Analysis of Pdx1^GFP/w ESCs modified by targeting a dsRed1 gene to the Ins1 locus (Pdx1^GFP/wIns1^RFP/w ESCs) provided corroborating evidence that insulin positive cells arose from GFP^br buds, mirroring the temporal relationship between pancreatic bud development and the formation of endocrine cells in the developing embryo. The readily detectable co-expression of GFP and RFP in grafts derived from transplanted EBs demonstrated the utility of Pdx1^GFP/wIns1^RFP/w ESCs for investigating pancreatic differentiation in vitro and in vivo.